With a broad spectrum of clinical manifestations, patients may be under the care of multiple specialists for seemingly unrelated inflammatory conditions, until the unifying diagnosis of VEXAS is confirmed by genetic testing for the UBA1 mutation. This evidence concerns the gene UBA1 and VEXAS syndrome.